Revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology.
Welcome to Syntach
“Over one million people worldwide suffer from severe heart failure and need mechanical circulatory support.”
“Over one million people worldwide suffer from severe heart failure and need mechanical circulatory support.”
The Syntach Cardiac Support (CS) Device
Two-thirds of cardiac output is due to the up and down movement of the mitral valve plane. The Syntach CS Device restores impaired movement of the mitral valve and naturally supports the heart. It is a permanent, active implant that can be inserted using a minimally invasive technique. It is smaller than existing left ventricle assist devices (LVADs) and is therefore suitable for both men and women of all sizes.
Syntach´s products are being developed and have not yet been approved for clinical use.
The Syntach Cardiac Support (CS) Device
Two-thirds of cardiac output is due to the up and down movement of the mitral valve plane. The Syntach CS Device restores impaired movement of the mitral valve and naturally supports the heart. It is a permanent, active implant that can be inserted using a minimally invasive technique. It is smaller than existing left ventricle assist devices (LVADs) and is therefore suitable for both men and women of all sizes.
Syntach´s products are being developed and have not yet been approved for clinical use.
A less invasive procedure, improved quality of life and a reduced risk of complications. These are some of the advantages in Prof. Jan Solem’s invention - an entirely new approach to the support of the cardiac function in patients with severe heart failure. The technology is applicable to a growing worldwide demographic of more than one million heart failure patients.
